Cullen Investment Group LTD. Takes $678,000 Position in Keurig Dr Pepper Inc. (NASDAQ:KDP)

Cullen Investment Group LTD. bought a new stake in Keurig Dr Pepper Inc. (NASDAQ:KDP) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 20,339 shares of the company’s stock, valued at approximately $678,000.

Several other institutional investors also recently modified their holdings of the business. OFI Invest Asset Management bought a new position in Keurig Dr Pepper during the third quarter valued at $25,000. Geneos Wealth Management Inc. grew its holdings in Keurig Dr Pepper by 973.8% during the third quarter. Geneos Wealth Management Inc. now owns 902 shares of the company’s stock valued at $28,000 after purchasing an additional 818 shares during the period. Turtle Creek Wealth Advisors LLC bought a new position in Keurig Dr Pepper during the fourth quarter valued at $29,000. Bruce G. Allen Investments LLC bought a new position in Keurig Dr Pepper during the fourth quarter valued at $34,000. Finally, Resurgent Financial Advisors LLC bought a new position in Keurig Dr Pepper during the fourth quarter valued at $34,000. 85.23% of the stock is owned by institutional investors.

Keurig Dr Pepper Trading Up 0.7 %

Shares of KDP stock opened at $30.43 on Tuesday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.25 and a current ratio of 0.38. Keurig Dr Pepper Inc. has a 52-week low of $27.66 and a 52-week high of $35.99. The company has a market capitalization of $42.22 billion, a PE ratio of 19.63, a price-to-earnings-growth ratio of 2.30 and a beta of 0.66. The business’s fifty day moving average is $30.27 and its 200 day moving average is $31.01.

Keurig Dr Pepper (NASDAQ:KDP) last released its quarterly earnings results on Thursday, February 22nd. The company reported $0.55 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.01. Keurig Dr Pepper had a return on equity of 9.93% and a net margin of 14.72%. The business had revenue of $3.87 billion for the quarter, compared to the consensus estimate of $3.92 billion. During the same quarter last year, the business posted $0.50 earnings per share. The company’s revenue for the quarter was up 1.7% on a year-over-year basis. On average, equities research analysts anticipate that Keurig Dr Pepper Inc. will post 1.91 EPS for the current fiscal year.

Keurig Dr Pepper Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were given a dividend of $0.215 per share. The ex-dividend date was Wednesday, March 27th. This represents a $0.86 dividend on an annualized basis and a yield of 2.83%. Keurig Dr Pepper’s payout ratio is 55.48%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on KDP shares. HSBC started coverage on Keurig Dr Pepper in a report on Friday, December 22nd. They issued a “hold” rating and a $37.00 price target for the company. Barclays raised their price target on Keurig Dr Pepper from $32.00 to $36.00 and gave the stock an “overweight” rating in a report on Friday. Royal Bank of Canada cut their price target on Keurig Dr Pepper from $42.00 to $41.00 and set an “outperform” rating for the company in a report on Friday, February 23rd. Jefferies Financial Group cut their price target on Keurig Dr Pepper from $37.00 to $35.00 and set a “buy” rating for the company in a report on Wednesday, March 27th. Finally, Wedbush cut their price target on Keurig Dr Pepper from $37.00 to $35.00 and set an “outperform” rating for the company in a report on Monday, February 26th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $36.45.

Insider Transactions at Keurig Dr Pepper

In other news, major shareholder Holdings B.V. Jab sold 51,956,522 shares of Keurig Dr Pepper stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $28.90, for a total value of $1,501,543,485.80. Following the transaction, the insider now owns 331,487,357 shares in the company, valued at $9,579,984,617.30. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, major shareholder Holdings B.V. Jab sold 51,956,522 shares of Keurig Dr Pepper stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $28.90, for a total value of $1,501,543,485.80. Following the transaction, the insider now owns 331,487,357 shares in the company, valued at $9,579,984,617.30. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Priyadarshi Sudhanshu acquired 85,910 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The stock was bought at an average price of $29.10 per share, for a total transaction of $2,499,981.00. Following the acquisition, the chief financial officer now owns 218,566 shares of the company’s stock, valued at approximately $6,360,270.60. The disclosure for this purchase can be found here. Over the last quarter, insiders have sold 100,012,132 shares of company stock worth $2,890,354,861. Company insiders own 0.81% of the company’s stock.

Keurig Dr Pepper Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.